Skip to main content
Elizabeth Wulff-Burchfield, MD, Oncology, Fairway, KS

ElizabethMarieWulff-BurchfieldMDMD(She/Her)

Oncology Fairway, KS

Genitourinary Oncology, Hospice & Palliative

Associate Professor of Medical Oncology and Palliative Medicine

Dr. Wulff-Burchfield is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wulff-Burchfield's full profile

Already have an account?

  • Office

    2650 Shawnee Mission Pkwy
    Fairway, KS 66205
    Phone+1 913-558-7750

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Hospice and Palliative Medicine, 2016 - 2017
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 2010 - 2013
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2010

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2017 - 2025
  • MO State Medical License
    MO State Medical License 2021 - 2025
  • TN State Medical License
    TN State Medical License 2013 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate
    Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the ProstateJanuary 5th, 2023

Professional Memberships